Ivan Kopljar,
Post Doctorial Research Scientist
Dr. Ivan Kopljar is a post doc scientist in the department of Global Safety Pharmacology at Janssen Pharmaceutica (J&J). His research focusses on the application of human stem cell-derived cardiomyocytes in drug safety. Currently, he is involved in the development of high throughput screening assays and investigation of drug-induced chronic cardiotoxicity using human stem cell-derived cardiomyocytes. Dr. Kopljar received his Ph.D. in Biochemistry from the University of Antwerp.
|
|
|
